Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS is cutting costs as it pushes deeper into healthcare services after its acquisitions of Signify Health and Oak Street Health.

CVS beats on earnings and revenue as the company slashes costs

WOONSOCKET, R.I. , Aug. 2, 2023 /PRNewswire/ -- CVS Health Corporation® (NYSE: CVS) today announced operating results for the three months ended June 30, 2023.

CVS Health reports second quarter results

Analysts at UBS have lowered their price target on CVS Health ahead of the pharmacy chain's second quarter results which will be handed down on Wednesday, August 2. The analysts wrote in a note to clients that since CVS management's last public commentary in May, negative peer news has emerged which has further muddied the outlook for CVS.

CVS Health price target lowered ahead of 2Q earnings on negative peer news concerns

Pharmacy giant CVS confirmed that its cutting thousands of corporate workers as it looks to "re-prioritize our investments around care delivery and technology."

CVS to lay off 5,000 employees as it seeks to cut costs

The job cuts are part of broader strategic changes at the pharmacy chain, but they will reportedly not impact consumer-facing retail staff. Massive layoffs are coming to CVS.

CVS Health is laying off thousands of employees: What's happening and why

CVS Health Corp (NYSE:CVS) announced on Tuesday that it will reduce its workforce by 5,000 positions in a cost-savings move as the drugstore chain broadens its focus to include more health-care offerings.   A spokesperson said the decision is part of an initiative to reprioritize investments around care delivery and technology and reduce expenses.

CVS Health to slash 5000 jobs as shift into health care continues

The pharmacy chain had about 300,000 employees in the U.S. at the end of last year, according to a securities filing.

CVS to slash 5,000 jobs as company deepens costly health care push

Layoffs continue apace after more than 136,000 employees were cut by major U.S. companies in the first quarter of 2023.

2023 Layoff Tracker: CVS Cuts 5,000 Jobs

CVS is laying off about 5,000 employees in a cost-cutting effort, the pharmacy chain confirmed Tuesday.

CVS is laying off 5,000 workers

The expanded offering supports the early diagnosis and management of Chronic Kidney Disease (CKD), impacting an estimated 37 million U.S. adults, many undiagnosed DALLAS and NEW YORK , Aug. 1, 2023 /PRNewswire/ -- Signify Health, a CVS Health company (NYSE: CVS), today announced the addition of a comprehensive in-home kidney health evaluation to its Diagnostic and Preventive Services offering. The new screenings expand Signify Health's suite of services designed to support the early detection, diagnosis, and management of some of the leading causes of morbidity and mortality among people covered under Medicare Advantage.

Signify Health Launches Chronic Kidney Disease Testing, Expands In-Home Diagnostic and Preventive Services Offering

Earnings will likely come in at about $2.10 on a per-share and adjusted basis, nearly matching the $2.11 consensus estimate.

Higher Costs To Weigh On CVS Health's Q2?

Several hedge funds led by billionaires have bought shares of CVS Health this year. These billionaires likely find CVS Health's valuation attractive.

Why Billionaires Are Loading Up on This Dirt-Cheap Stock

CVS said the jobs affected are primarily corporate positions and it doesn't expect customer-oriented roles to be affected, The Wall Street Journal reported.

CVS to Shed 5,000 Jobs in Cost-Cutting Push Just Months After Acquisitions

CVS Health plans to shed 5,000 jobs across the country in the wake of billions of dollars the retail drugstore giant has spent on healthcare services.

As CVS Adds More Healthcare Services, 5,000 Job Cuts And Restructuring Ahead

CVS Health Corp. will slash about 5,000 jobs in a cost-cutting move, the Wall Street Journal reported Monday night. According to the report, the layoffs are primarily in corporate positions, and the company doesn't expect customer-facing positions in its stores, clinics and pharmacies to be affected.

CVS to cut about 5,000 corporate jobs: report

The healthcare giant wants to trim corporate roles and spending on travel and its use of consultants.

CVS to Shed 5,000 Jobs in Cost-Cutting Push

Cameco

Kraft Heinz

Before markets opened on Monday, SoFi Technologies beat the consensus estimate for its second-quarter per-share loss by a penny and beat the consensus revenue estimate by about 3.2%.

Earnings Previews: Cameco, CVS Health, Kraft Heinz

Agree Realty

Kohl's

NETLease Corporate Real Estate ETF

Realty Income Corp

Walgreens

Net lease REITs have historically been solid performers. Elevated interest rates create some headwinds. So does an elevated likelihood of investment grade tenant credit migration.

Net Lease REITs In A New Era

Dow Inc

Energy Transfer LP Unit

Ford Motor Company

ManpowerGroup

MetLife

Omnicom Group

Pfizer

Philip Morris

Raytheon Technologies

Southern Company

Sysco

Verizon

WestRock

Exxon Mobil

The latest edition of Fortune Magazine revealed 500 of the biggest U.S. companies by revenue. To sniff out the best dividend buys, this month, we focus on 68 industry leaders. Those 68 industry leaders were segmented into 21 business sectors ranging from apparel to transportation. 58 dividend-yielding stocks highlighted those 68 industry leaders and ranged 0.16% to 9.31% in annual yield.

Buy 5 Fortune 500 Industry Leaders In July-August And Watch 4 More

CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: CVS Health (CVS) Q2 Earnings Expected to Decline

Advance Auto Parts

American Tower

Crown Castle International

Dollar General

O'Reilly Automotive

Walmart

I began writing on Seeking Alpha because I enjoy writing and because it provided me with an opportunity to share investing ideas and strategies with other like-minded investors. Today I want to continue with my “lessons learned” series. Now, whenever I decide to invest in a stock, business, or direct real estate, I always ask myself “is the thrill of victory worth the agony of defeat?"

Is The Thrill Of Victory Worth The Agony Of Defeat?

Alphabet

Riding Warren Buffett's coattails has been making investors richer for decades. Due to an acquisition a quarter of a century ago, Berkshire Hathaway owns a specialty investment company that's effectively Buffett's "secret" portfolio.

3 Magnificent Stocks Being Added Hand Over Fist to Warren Buffett's Secret Portfolio

CVS Pharmacy exclusive beauty and personal care brand, one+other, puts accessibility at the forefront with inclusively designed self-care tools. WOONSOCKET, R.I.

CVS Pharmacy introduces new universal tools collection from one+other

Amazon

In the dynamic investment landscape, the spotlight often falls on the hottest sectors, attracting a swarm of investors. Yet savvy traders understand the attractiveness of value stocks which offer tremendous upside potential.

3 Value Stocks for Safe, Stable Portfolio Balance

CVS Health is trading at a significant discount, with its price-to-earnings valuation below its five-year average. CVS Health has diversified away from being a brick-and-mortar retailer, acquiring Aetna, Signify Health and Oak Street Health, which has not yet been fully recognized by investors. Despite an expected EPS decline of just over 1% in 2023, I believe CVS is undervalued with high financial flexibility and steady cash flow, making it a recommended long-term hold.

News for CVS Health Stock (CVS)